{
  "N/R/U": null,
  "Applicant": "AstraZeneca AB",
  "BLA Number": "761070",
  "Proprietary Name": "Fasenra",
  "Proper Name": "benralizumab",
  "BLA Type": "351(a)",
  "Strength": "10MG/0.5ML",
  "Dosage Form": "Injection ",
  "Route of Administration": "Subcutaneous",
  "Product Presentation": "Pre-Filled Syringe",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "5-Apr-24",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": "20",
  "Submission Type": "Supplement",
  "License Number": "2059",
  "Product Number": "3",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": "17-Sep-31"
}